Doctor profile · Federal record
Dr. Christopher Englert, N.P.
Adult Health Nurse Practitioner (CMS: Nurse Practitioner) · Sparks, MD
- NPI 1578651485
- Accepts Medicare
- MIPS 87.7 / 100 · 2023
- 26 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
10 Fila Way, Ste. 205
Sparks, MD 211529452
(410) 472-1006
fax (410) 472-0900
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 363LA2200X — NUCC code
- State license (1)
- Maryland #R170272
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578651485. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,609
Distinct HCPCS
10
Medicare allowed
$171,719
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 816 | 661 | $82 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 566 | 173 | $6 | |
17000 |
Destruction of precancer skin growth, 1 growth | 316 | 273 | $52 | |
17110 |
Destruction of skin growth, 1-14 growths | 283 | 251 | $106 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 158 | 149 | $52 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 122 | 122 | $103 | |
11102 |
Biopsy of related skin growth, first growth | 111 | 106 | $86 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 60 | 53 | $116 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 38 | 38 | $66 | |
J9260 |
Methotrexate sodium, 50 mg | 31 | 25 | $2 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 173. This provider delivers 15× the peer median.Open Payments
Industry payments received
All-time total
$1,801
Transactions
69
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 25 | $372.18 | |
| UCB, Inc. | 6 | $300.80 | |
| REVANCE THERAPEUTICS, INC. | 2 | $187.84 | |
| Dermavant Sciences, Inc. | 2 | $177.34 | |
| Novartis Pharmaceuticals Corporation | 6 | $144.33 | |
| ABBVIE INC. | 10 | $142.20 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $96.42 | |
| GENZYME CORPORATION | 3 | $91.13 | |
| Galderma Laboratories, L.P. | 4 | $77.05 | |
| Verrica Pharmaceuticals Inc. | 2 | $49.38 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $48.52 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $45.31 | |
| Lilly USA, LLC | 1 | $21.34 | |
| Medimetriks Pharmaceuticals, Inc. | 1 | $17.40 | |
| PFIZER INC. | 1 | $16.68 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
577
Patients
397
Total drug cost
$30,304
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 181 | 127 | $1,964 |
| Clobetasol Propionate | Generic | 94 | 65 | $7,070 |
| Hydrocortisone | Generic | 93 | 63 | $604 |
| Fluorouracil | Generic | 78 | 71 | $8,354 |
| Ketoconazole | Generic | 66 | 42 | $1,871 |
| Clindamycin Phosphate | Generic | 24 | 13 | $1,286 |
| Imiquimod | Generic | 16 | 16 | $489 |
| Metronidazole | Generic | 13 | 0 | $781 |
| Doxycycline Ir-Dr (Doxycycline Monohydrate) | Brand | 12 | 0 | $7,886 |
Frequently asked questions
What is Dr. Christopher Englert's medical specialty?
Dr. Christopher Englert practices Adult Health Nurse Practitioner in Sparks, MD.
Where does Dr. Christopher Englert practice?
Dr. Christopher Englert practices at 10 Fila Way, Sparks, MD 211529452. Office phone: 4104721006.
What is Dr. Christopher Englert's NPI?
Dr. Christopher Englert's National Provider Identifier (NPI) is 1578651485, issued by NPPES.
Does Dr. Christopher Englert accept Medicare assignment?
Yes. Dr. Christopher Englert accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Englert commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.